LeonaBio, Inc. Common Stock LONA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$129.41M-22.5% | -$105.61M-180% | -$37.72M+37.0% | -$59.85M+24.9% | -$79.75M+17.7% | ||
| $874K-1.4% | $886K0.0% | $886K0.0% | $886K0.0% | $886K+0.1% | ||
| $5.13M-16.0% | $6.1M-11.2% | $6.87M-18.2% | $8.4M-16.1% | $10.01M-9.4% | ||
| -$17.05M+20.1% | -$21.34M-42.1% | -$15.01M— | —— | —— | ||
| -$1.69M+30.7% | -$2.44M— | —— | —— | —— | ||
| -$227.25K-285% | -$59K— | —— | —— | —— | ||
| $282K+3.3% | $273K+3.4% | $264K+2.7% | $257K+3.2% | $249K+3.3% | ||
| -$426K-2.9% | -$414K-3.0% | -$402K-3.1% | -$390K-2.4% | -$381K-3.5% | ||
| -$51.97M-13.6% | -$45.73M+12.6% | -$52.35M+26.0% | -$70.7M+17.8% | -$86.03M+11.5% | ||
| —— | —— | —— | —— | —— | ||
| $48.06M+27.7% | $37.64M+67.9% | $22.42M+17.5% | $19.08M+3.6% | $18.42M+30.4% | ||
| $23.97M+10.2% | $21.75M+18.5% | $18.35M-33.0% | $27.4M-48.2% | $52.89M-23.3% | ||
| —— | —— | —— | —— | $37.25M-35.4% | ||
| —— | —— | —— | —— | —— | ||
| $6.41M-69.2% | $20.84M+137% | -$56.36M+9.6% | -$62.31M— | —— | ||
| $524K+59.3% | $329K+13.8% | $289K+4.7% | $276K-12.1% | $314K-39.0% | ||
| $874K-1.4% | $886K0.0% | $886K0.0% | $886K0.0% | $886K+0.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$426K-2.9% | -$414K-3.0% | -$402K-3.1% | -$390K-2.4% | -$381K-3.5% | ||
| -$227.25K-285% | -$59K— | —— | —— | —— | ||
| -$1.69M+30.7% | -$2.44M— | —— | —— | —— | ||
| $282K+3.3% | $273K+3.4% | $264K+2.7% | $257K+3.2% | $249K+3.3% | ||
| $23.97M+10.2% | $21.75M+18.5% | $18.35M-33.0% | $27.4M-48.2% | $52.89M-23.3% | ||
| —— | $7.57M— | —— | —— | —— | ||
| —— | $37K-51.5% | $76.25K-34.0% | $115.5K-25.4% | $154.75K-20.2% | ||
| $19.75M+331% | $4.58M— | —— | —— | —— | ||
| -$426K-2.9% | -$414K-3.0% | -$402K-3.1% | -$390K-2.4% | -$381K-3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does LeonaBio, Inc. Common Stock generate?
- LeonaBio, Inc. Common Stock (LONA) generated -$52.0M in operating cash flow over the trailing twelve months.
- What is LeonaBio, Inc. Common Stock's free cash flow?
- After $63.0K of capital expenditures, LeonaBio, Inc. Common Stock's free cash flow was -$97.2M over the trailing twelve months, up 3.8% year over year.
- Where does LeonaBio, Inc. Common Stock's cash flow data come from?
- Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.